Figure 1From: A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern SudanTrial profile, showing number of patients enrolled, treated and completing the 28 days of follow-up after the treatment with fixed or loose combinations of AS+SMPBack to article page